These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2434194)

  • 21. Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration.
    Wassef M; Berod A; Sotelo C
    Neuroscience; 1981; 6(11):2125-39. PubMed ID: 6120482
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined use of silver staining of the retrograde tracer WGAapoHRP-Au and pre-embedding immunocytochemistry for electron microscopy: demonstration of dopaminergic terminals in synaptic contact with striatal neurons projecting to the substantia nigra in the rat.
    Arai R; Kojima Y; Geffard M; Kitahama K; Maeda T
    J Histochem Cytochem; 1992 Jun; 40(6):889-92. PubMed ID: 1588034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat.
    Smith Y; Bolam JP
    J Comp Neurol; 1990 Jun; 296(1):47-64. PubMed ID: 1694189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ascending projections of the dopaminergic neurons of the substantia nigra, zona reticulata: a combined retrograde tracer-immunohistochemical study.
    Deutch AY; Goldstein M; Roth RH
    Neurosci Lett; 1986 Nov; 71(3):257-63. PubMed ID: 2879262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Melis MR; Gale K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin-peroxidase and protein A-colloidal gold.
    van den Pol AN; Smith AD; Powell JF
    Brain Res; 1985 Nov; 348(1):146-54. PubMed ID: 2866017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra.
    Cumming P; Kamo H; McGeer EG; McGeer PL
    Neuropharmacology; 1987 Dec; 26(12):1795-7. PubMed ID: 2893988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural single- and double-label immunohistochemical studies of substance P-containing terminals and dopaminergic neurons in the substantia nigra in pigeons.
    Anderson KD; Karle EJ; Reiner A
    J Comp Neurol; 1991 Jul; 309(3):341-62. PubMed ID: 1717517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation.
    Caillé I; Dumartin B; Bloch B
    Brain Res; 1996 Aug; 730(1-2):17-31. PubMed ID: 8883884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine-sensitive adenylate cyclase: location in substantia nigra.
    Gale K; Guidotti A; Costa E
    Science; 1977 Feb; 195(4277):503-5. PubMed ID: 13499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat.
    Tamiya R; Hanada M; Kawai Y; Inagaki S; Takagi H
    Neurosci Lett; 1990 Mar; 110(1-2):11-5. PubMed ID: 1691469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions.
    Walker PD; Riley LA; Hart RP; Jonakait GM
    Brain Res; 1991 Aug; 557(1-2):31-6. PubMed ID: 1720996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin terminals form synapses primarily with neurons lacking detectable tyrosine hydroxylase immunoreactivity in the rat substantia nigra and ventral tegmental area.
    Woulfe J; Beaudet A
    J Comp Neurol; 1992 Jul; 321(1):163-76. PubMed ID: 1351897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A; Zivkovic B; Bartholini G
    Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
    Pioro EP; Hughes JT; Cuello AC
    Brain Res; 1984 Feb; 292(2):339-47. PubMed ID: 6198046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamic acid decarboxylase and enkephalin immunoreactive axon terminals in the rat neostriatum synapse with striatonigral neurons.
    Aronin N; Chase K; DiFiglia M
    Brain Res; 1986 Feb; 365(1):151-8. PubMed ID: 3512036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo synthesis of substance P in the corpus striatum of the rat and its transport to the substantia nigra.
    Sperk G; Singer EA
    Brain Res; 1982 Apr; 238(1):127-35. PubMed ID: 6177379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.